FUL
H. B. Fuller Company
Latest News for FUL
In a report released today, from Roth MKM reiterated a Buy rating on Fulcrum Therapeutics, with a price target of $15.00. In addition to Roth MKM, ......
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Incyte (INCY – Research Report), Fulcrum Therapeut......
In a report released on December 6, Kristen Kluska from Cantor Fitzgerald maintained a Buy rating on Fulcrum Therapeutics, with a price target of $......
In a report released today, James Condulis from Stifel Nicolaus maintained a Buy rating on Fulcrum Therapeutics, with a price target of $20.00. Con......
Oppenheimer analyst Matthew Biegler reiterated a Buy rating on Fulcrum Therapeutics today and set a price target of $15.00. Biegler covers the Heal......
Fulcrum Therapeutics ( ($FULC) ) just unveiled an announcement. On December 6, 2025, Fulcrum Therapeutics announced positive initial results from t......
Truist Financial analyst maintained a Buy rating on Fulcrum Therapeutics yesterday. The company’s shares closed yesterday at $9.06. In addition to ......
Fulcrum Lithium Ltd. ( ($AU:FUL) ) has issued an update. Fulcrum Lithium Ltd. has announced a presentation at their Annual General Meeting, schedul......
An update from Fulcrum Lithium Ltd. ( ($AU:FUL) ) is now available. Fulcrum Lithium Ltd. has announced the initiation of the Dry Canyon lithium cla......
Fulton Financial ( ($FULT) ) just unveiled an announcement. On November 24, 2025, Fulton Financial Corporation announced a merger agreement with Bl......
News data is sourced from MarketXLS API and updated regularly.
Showing 10 of 12 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | FUL | $60.39 | -0.9% | 403.91K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |